Cardiovascular Medicine
Showing page 3 of 17 pages of list content
-
ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
This article's authors -
The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study
This article's authors -
Mortality and use of angiotensin converting enzyme inhibitors in Covid 19 disease – a systematic review
This article's authors -
Renin-angiotensin-aldosterone system inhibitors and mortality in patients with hypertension hospitalized for COVID-19: a systematic review and meta-analysis
This article's authors -
Hypertension and renin-angiotensin system blockers are not associated with expression of Angiotensin Converting Enzyme 2 (ACE2) in the kidney
This article's authors -
Association between Cardiovascular Burden and Requirement of Intensive Care among Patients with Mild COVID-19
This article's authors -
Error retrieving metadata for 10.1101/2020.05.20.20108399
This article's authors -
Association of Renin Angiotensin System Blockers with Outcomes in Patients with Covid-19: A Systematic Review and Meta-analysis
This article's authors -
Antihypertensive medication uses and serum ACE2 levels
This article's authors -
Cardiac Structural and Functional Characteristics in Patients with Coronavirus Disease 2019: A Serial Echocardiographic Study
This article's authors